UBS Group’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
271,904
+239,822
| +748% | +$964K | ﹤0.01% | 4293 |
|
|
2025
Q1 | $111K | Sell |
32,082
-18,972
| -37% | -$65.8K | ﹤0.01% | 5707 |
|
|
2024
Q4 | $336K | Buy |
51,054
+39,942
| +359% | +$263K | ﹤0.01% | 4948 |
|
|
2024
Q3 | $100K | Buy |
11,112
+7,983
| +255% | +$72.2K | ﹤0.01% | 5180 |
|
|
2024
Q2 | $50.2K | Sell |
3,129
-7,238
| -70% | -$116K | ﹤0.01% | 5544 |
|
|
2024
Q1 | $163K | Buy |
+10,367
| New | +$163K | ﹤0.01% | 4837 |
|